Cancer Research KI list of basic cancer research PIs across KI

Please find the basic science researchers within the cancer area at KI listed in the table below.

Note that this is an initial list that may still contain errors in part because the response rate on the conducted survey was below a hundred per cent. We would therefore like you to be in contact with us if you find that your name has been erroneously entered or if you would like to complete the current information in any way. Please send your update request to

Contact details for the researchers can be found through the KI search function on the top right-hand side of this page.

Basic cancer research

Basic cancer research
Surname Given name Department Group website Description
Andersson Björn CMB The use of virus metagenomics to study viruses in paediatric and other cancers.
Arnér Elias MBB Redox signaling, selenoproteins, thioredoxin system, glutathione peroxidases and biochemistry. Targeting of selenoproteins as anticancer therapy, triggering ferroptosis, transcription factor regulation, Nrf2 modulation and metabolic pathway switches.
Arvidsson Per MBB
Baranello Laura CMB We use biochemical and genomic approaches as well as drug screens to understand the mechanism of topoisomerases in transcription and how to target this mechanism to arrest cancer cell growth
Belkic Dzevad Onk-Pat
Bergö Martin BioNut Basic and translational cancer research on molecular mechanisms of tumor initiation, progression, and metastasis
Betsholtz Christer MedH
Bienko Magda MBB
Björkegren Camilla BioNut Basic medically relevant research on chromosome stability and dynamics. In vivo and in vitro.
Björkhem Ingemar LabMed
Björnstedt Mikael LabMed
Blomqvist Lennart MMK
Cao Yihai MTC
Crosetto Nicola MBB Development of novel sequencing approaches for profiling tumor heterogeneity and studying genome fragility and structure in cancer. 1) Cancer genomics; 2) Genome instability and 3D genome organization in cancer
Dantuma Nico CMB Exploring intracellular protein degradation, in particular the ubiquitin-proteasome system, as therapeutic target.
Díaz De Ståhl Teresita Onk-Pat
Dreij Kristian IMM
Einhorn Stefan Onk-Pat
Ekwall Karl BioNut
Elsässer Simon MBB Cancer epigenomics, oncogenic histone mutants,G4 structures, ssDNA and SSB mapping
Enge Martin Onk-Pat Single-cell genomics of cancer, with a focus on childhood leukemia and pancreatic cancer.
Eriksson Maria Bionut
Espinosa Alexander MedS
Fadeel Bengt IMM
Farnebo Marianne Bionut
Fernandez-Capetillo Oscar MBB I try to combine mouse models, cell biology and genetic and chemical screens for developing new therapies.
Gabrielsson Susanne MedS The role of cancer-derived exosomes in disease and how to use exosomes for therapy.
Genové Guillem MedH To understand the role of pericytes in tumors and their role in immune cell recruitment
Girnita Leonard Onk-Pat
Göndör Anita Onk-Pat
Grafström Roland IMM
Gustafsson Nina Onk-Pat Our research is focused on understanding how altered metabolism can regulate the DNA repair capacity of cancer cells with the goal to translate our findings into novel treatments for cancer patients.
Hausser Jean CMB We research quantitative rules in tumor biology. We aim to formulate these rules in the form of equations that state how key tumor properties relate to each other: cellular composition of the tumor, functional heterogeneity among cells found in the tumor, spatial organization, tumor growth rate, tumor size, shedding rate of metastatic cells, and so on. Finding mathematical order in the complexity of the tumor micro-environment could support diagnostics, prognosis and inform the design of immunotherapy in the future. It could also enhance ongoing efforts to apply artificial intelligence and machine-learning techniques to cancer.
Helleday Thomas Onk-Pat Basic research into DNA damage response and repair and translating to novel treatments and clinical trials.
Högberg Johan IMM
Högberg Björn MBB
Holmgren Lars Onk-Pat
Höög Christer CMB Segregation of chromosomes at the metaphase/anaphase stage of the cell cycle during mitosis and meiosis.
Jacobsson Hans MMK
Jakobsson Per-Johan MedS Role of prostaglandin E2 and microsomal prostaglandin E synthase inhibition in cancer
Jakobsson Lars MBB Blood vessels in the context of tumour biology. Angiogenesis, fibrosis, and matrix biology in genetic mouse models.
Johnson Randall CMB Hypoxia and its role in tumor pathology and immunotherapy
Kutter Claudia MTC We investigate how gene regulation and transcriptional complexity contributes to cancerogenesis. We are particularly interested in dissecting the roles of non-coding and coding RNAs interact by using and developing -omics approaches, CRISPR technology and phenotypical screening.
Lain Sonia MTC Cancer drug discovery: from phenotypic screens to the identification of the mechanism of action for small molecules.
Landreh Michael MTC
Lane David MTC
Larsson Ola Onk-Pat Studies of how mRNA translation is dysregulated in cancer. Identification of potential avenues for treatment by targeting dysregulated mRNA translation.
Larsson Olle Onk-Pat
Larsson Nils-Göran MBB We work on the development of drugs for cancer treatment by inhibiting mitochondrial transcription and translation.
Larsson Lars-Gunnar MTC
Lehti Kaisa MTC
Lehtiö Janne Onk-Pat Proteomics and multi-omics driven cancer research with focus on lung and breast cancer as well as leukemia. Experimental cancer systems biology and predictive biomarker research.
Lemmens Bennie MBB The Lemmens laboratory tries to understand how dividing cells maintain genome stability and based on that knowledge find innovative ways to tackle cancer and drug resistance. We develop time-resolved genetics and cutting-edge imaging technologies to determine how human cells maintain, copy and propagate DNA.
Lindqvist Arne CMB
Linnarsson Sten MBB
McInerney Gerald MTC
Menendez Benito Victoria BioNut
Morgenstern Ralf IMM
Nilsson Roland MedS My group studies cancer metabolism, particularly one-carbon and methionine metabolism, striving to identify new drug targets. We use large-scale metabolomics techniques and stable isotope tracing to measure metabolism.
Norberg Helin FyFa Our ultimate goal is to understanding how pathogenic proteins can be eliminated by degradation pathways in cancer cells. In particular our research focuses on oncogenic targeting.
Nordenskjöld Magnus MMK
Nordlund Pär Onk-Pat
Ohlsson Rolf Onk-Pat
Page Brent Onk-Pat We use state of the art chemical biology and medicinal chemistry techniques to identify novel cancer therapeutic agents.
Panaretakis Theocharis IMM
Patarroyo Manuel MTC Decoding the molecular basis of tumor aggressiveness (tumor growth, invasion, metastasis and chemoresistance) to develop novel therapeutic strategies
Pawitan Yudi MEB
Pelechano Garcia Vicente MTC We work on the fundamental aspects of gene expression controlling cell-to-cell variability in cancer, with a focus on Epigenetics, transcription and ribosome dynamics.
Pereira Teresa MMK
Petzold Katja MBB We work on RNA biophysics and structural biology, with focus on microRNA, ribosomes, viral RNA & drug development
Pietrocola Federico BioNut
Rannug Agneta IMM
Riedel Christian BioNut… We are interested in a) aneuploidy (one of the hallmarks of cancer) and b) the communication between cancer cells and their surroundings.
Rolny Charlotte Onk-Pat We are studying the underlying mechanisms that regulate macrophages immunosuppressive and prometastatic functions.
Rudd Sean Onk-Pat The Rudd lab investigates metabolic pathways operating inside cancer cells and how these pathways support malignant disease. We are particularly focused upon the metabolic interplay between the DNA precursor pool and the DNA molecule, a relationship that is fundamental to cancer biology, underpinning key aspects of oncogenesis together with therapy resistance.
Sandberg Rickard CMB
Schlisio Susanne MTC cancer arising from the sympathoadrenal lineage, such as neuroblastoma and pheochromocytoma
Schüler Herwig BioNut Pre-clinical development of PARP inhibitors
Schulte Gunnar FYFA Molecular understanding of WNT and Frizzled signaling with special emphasis on drug discovery for anticancer therapy targeting Frizzleds.
Selivanova Galina MTC p53 biology, small molecules restoring p53, anti-cancer therapy
Strang Peter Onk-Pat
Ström Lena CMB Importance of chromosome organization and DNA repair for genome integrity.
Strömblad Staffan BioNut Role of Cell-matrix interactions andCellular signaling in Cancer
Svensson Peter BioNut… Mechanistic insights into the (mis)regulation of transcription and chromatin
Szekely Laszlo LabMed High throughput drug sensitivity measurement of primary human tumors
Taipale Jussi MBB
Teixeira Ana MBB We investigate how the organisation of membrane proteins at the nanoscale affects their functions in normal and cancer cells.
Tham Emma MMK "Hereditary cancer syndromes - genetic causes and phenotypic characterisationCell-free tumour DNA as a biomarker for diagnosis, prognosis and monitoring of cancer"
Treuter Eckardt BioNut
Uhlén Per MBB Our group studies the intratumoral heterogeneity in various types of human cancer. We explore cancer stem cells, cell niches, and the tumor vasculature in intact tumor samples.
Walfridsson Julian MedH
Warpman Berglund Ulrika onk-Pat The research aims to i) purifying and targeting proteins in DNA repair and metabolism, ii) use probes and genetic tools to increase basic knowledge around target proteins and iii) translating basic research findings into new treatments tested in clinic
Wedell Anna MMK
Wiman Klas Onk-Pat Tumor biology, tumor suppressor genes, p53, cell death, cancer drug discovery, APR-246, clinical trials
Xu Dawei MedS
Zinzalla Giovanna MTC Targeting two masters of transcriptional regulation: the MYC family of transcriptions and the SWI/SNF (BAF) chromatin remodelling complexes using biochemistry, biophysics and structural biology to determine key protein-protein interactions, and chemistry methods to develop new synthetic agents as potential therapeutics.
Zubarev Roman MBB Chemical proteomics of cancer cells and cancer stem cells
Åkesson Agneta IMM Diet and environmental contaminants and risk of cancer target this mechanism to arrest cancer cell growth
Östling Päivi Onk-Pat Precision cancer medicine. We are linking spatial tissue maps to drug profiles for patient stratification and treatment prediction.
Östman Arne Onk-Pat Translational studies on tumor microenvironment with focus on cancer-associated fibroblasts